Trillium Asset Management LLC bought a new stake in Quintiles Transitional Holdings Inc. (NYSE:Q) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 29,577 shares of the medical research company’s stock, valued at approximately $2,647,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Buffington Mohr McNeal raised its position in Quintiles Transitional Holdings by 0.5% in the first quarter. Buffington Mohr McNeal now owns 14,425 shares of the medical research company’s stock valued at $1,162,000 after buying an additional 75 shares during the period. Shell Asset Management Co. raised its position in Quintiles Transitional Holdings by 1.0% in the first quarter. Shell Asset Management Co. now owns 8,769 shares of the medical research company’s stock valued at $706,000 after buying an additional 83 shares during the period. Bbva Compass Bancshares Inc. raised its position in Quintiles Transitional Holdings by 4.2% in the second quarter. Bbva Compass Bancshares Inc. now owns 2,204 shares of the medical research company’s stock valued at $197,000 after buying an additional 88 shares during the period. Pacer Advisors Inc. raised its position in Quintiles Transitional Holdings by 3.2% in the first quarter. Pacer Advisors Inc. now owns 3,738 shares of the medical research company’s stock valued at $301,000 after buying an additional 116 shares during the period. Finally, American Century Companies Inc. raised its position in Quintiles Transitional Holdings by 1.1% in the first quarter. American Century Companies Inc. now owns 11,719 shares of the medical research company’s stock valued at $944,000 after buying an additional 128 shares during the period. 91.79% of the stock is owned by institutional investors and hedge funds.

Shares of Quintiles Transitional Holdings Inc. (Q) opened at 91.53 on Wednesday. The firm has a market capitalization of $19.82 billion, a P/E ratio of 265.30 and a beta of 0.64. Quintiles Transitional Holdings Inc. has a 52 week low of $70.10 and a 52 week high of $93.53. The stock has a 50 day moving average price of $90.02 and a 200 day moving average price of $83.84.

Quintiles Transitional Holdings (NYSE:Q) last released its quarterly earnings results on Thursday, August 3rd. The medical research company reported $1.09 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.05 by $0.04. Quintiles Transitional Holdings had a net margin of 0.82% and a return on equity of 14.23%. The company had revenue of $1.97 billion during the quarter, compared to the consensus estimate of $1.96 billion. During the same period in the prior year, the firm earned $0.93 earnings per share. Quintiles Transitional Holdings’s revenue was up 68.7% on a year-over-year basis. Analysts forecast that Quintiles Transitional Holdings Inc. will post $4.58 EPS for the current year.

Quintiles Transitional Holdings declared that its Board of Directors has authorized a share buyback plan on Wednesday, May 24th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the medical research company to buy up to 5.4% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s board believes its shares are undervalued.

WARNING: “Trillium Asset Management LLC Buys Shares of 29,577 Quintiles Transitional Holdings Inc. (Q)” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/16/trillium-asset-management-llc-buys-shares-of-29577-quintiles-transitional-holdings-inc-q.html.

Several research analysts have recently weighed in on the company. Barclays PLC reissued an “overweight” rating and issued a $98.00 price objective (up from $90.00) on shares of Quintiles Transitional Holdings in a research report on Monday, July 17th. William Blair raised Quintiles Transitional Holdings from a “market perform” rating to an “outperform” rating and lifted their price objective for the stock from $70.10 to $93.42 in a research report on Friday, August 4th. Jefferies Group LLC reissued a “hold” rating and issued a $94.00 price objective on shares of Quintiles Transitional Holdings in a research report on Friday, August 4th. Citigroup Inc. lifted their price objective on Quintiles Transitional Holdings from $96.00 to $97.00 and gave the stock a “neutral” rating in a research report on Monday, August 7th. Finally, Stifel Nicolaus reissued a “hold” rating and issued a $92.00 price objective (up from $87.00) on shares of Quintiles Transitional Holdings in a research report on Friday, August 4th. Eleven research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Quintiles Transitional Holdings currently has an average rating of “Hold” and a consensus price target of $89.94.

In other Quintiles Transitional Holdings news, insider Ari Bousbib sold 92,160 shares of the firm’s stock in a transaction that occurred on Monday, August 7th. The shares were sold at an average price of $90.35, for a total transaction of $8,326,656.00. Following the completion of the transaction, the insider now owns 1,082,919 shares of the company’s stock, valued at $97,841,731.65. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Kevin C. Knightly sold 20,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 9th. The shares were sold at an average price of $90.28, for a total transaction of $1,805,600.00. Following the transaction, the insider now directly owns 46,826 shares of the company’s stock, valued at approximately $4,227,451.28. The disclosure for this sale can be found here. Over the last three months, insiders sold 8,864,468 shares of company stock valued at $745,413,651. 6.40% of the stock is owned by insiders.

Quintiles Transitional Holdings Company Profile

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Institutional Ownership by Quarter for Quintiles Transitional Holdings (NYSE:Q)

Receive News & Stock Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related stocks with our FREE daily email newsletter.